What is Depression Phase 2 Ketamine Clinical Trial?
CATEGORY:
Depression Phase 2 Ketamine Clinical Trial is an interventional study to determine whether specific doses of ketamine are superior to placebo therapy in treatment resistant depression. Identifier: NCT01920555
Save up to 80% off your prescriptions!
How do members experience Depression Phase 2 Ketamine Clinical Trial?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Major depressive disorder | 3 | 1 | |
| Anxiety attacks | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |
Learn more about our community’s experience with Depression Phase 2 Ketamine Clinical Trial
What are people saying about Depression Phase 2 Ketamine Clinical Trial?
8
8
members have reported taking Depression Phase 2 Ketamine Clinical Trial
Join the conversation and connect with people who have taken Depression Phase 2 Ketamine Clinical Trial
Last updated: